President Donald Trump's latest round of tariffs could hit M&A activity hard, primarily by creating uncertainty, raising ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

Economists at Piper Sandler, an investment bank, said that President Trump’s tariffs are more dramatic and darker for the U.S ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Opko Health (OPK – Research Report), with a price ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics ...

Investing.com -- 2025 could emerge as a potential turning point for consumer-facing AI applications, marking a shift from the infrastructure-led boom to widespread integration of AI at the application ...

Mizuho views Alibaba’s AI strategy as built on three core pillars: intelligence (scaling its Qwen LLM to AGI), enterprise ...

Sales of the 1980s basketball shoe worn more on the streets these days than on the court, are expected to plummet 70% over ...

Investing.com -- Piper Sandler assumed coverage of V.F. Corporation with a Neutral rating and a price target of $18, citing ...

Indian IT services firms are rewiring their traditional business model to offset headwinds from artificial intelligence, ...